NCT01527136View on ClinicalTrials.gov

Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

entolimod

Given IM or SC

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

Sponsors

Collaborators (1)

Cleveland BioLabs, Inc.

All Listed Sponsors

collaborator

Cleveland BioLabs, Inc.

INDUSTRY

lead

Roswell Park Cancer Institute

OTHER